We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WTBA:NASDAQWest Bancorporation Analysis

Data as of 2026-08-08 - not real-time

$28.43

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

West Bancorporation, Inc. trades at $28.43, with its short-term moving averages stacked above the longer-term ones — a bullish trend structure. Over a rolling month the price has gained 9.8%. Momentum indicators put RSI at 65.6 (approaching overbought) with MACD reading bullish. Price has been bracketed by support at $25.87 and resistance at $28.80.
Valuation screens as fair: a P/E of 12.6 sits below the sector average of 16.9. Revenue is growing at 18.0% on a 37.1% profit margin. The 3.67% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 4 — moderate. With 30-day volatility of 24.1%, a beta of 0.56 and a maximum drawdown of 13.8%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: buy, at a conviction of 6 out of 10.

Top Market Events

The bank's net income jumped 38.8% year-over-year as deposit costs fell 46 basis points, widening the net interest...West Bancorporation NASDAQ:WTBA reported stronger second-quarter 2026 earnings, higher net interest income and...WEST DES MOINES, Iowa, July 23, 2026 GLOBE NEWSWIRE -- West Bancorporation, Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 24.04
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 12.6 versus sector average of 16.9
  • Trading above the 200-day average of 24.04

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • P/E of 12.6 versus sector average of 16.9
  • Profit margin of 37.1% is healthy
  • Revenue growth of +18.0%

Key Metrics & Analysis

Financial Health

Revenue Growth18.00%
Profit Margin37.13%
P/E Ratio12.6
ROE14.71%
ROA0.95%
P/B Ratio1.7
Op. Cash Flow$50.5M
Industry P/E16.9

Technical Analysis

TrendBullish
RSI65.6
Support$25.87
Resistance$28.80
MA 20$27.55
MA 50$26.19
MA 200$24.04
MACDBullish
VolumeStable
Fear & Greed Index94.82

Valuation

Fair Value$59.27
Target Price$29.00
Upside/Downside2.00%
GradeFair
TypeBlend
Dividend Yield3.67%

Risk Assessment

Beta0.56
Volatility24.09%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.